EXAGEN INC. (XGN) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-04-23

Key Insights

Ana Hooker resigned from the Board effective April 17, 2026, reducing board size from 8 to 7 members; her departure was voluntary and not due to any disagreement with company operations or policies.
Hooker held significant board positions as a member of the Audit Committee and chair of the Nominating and Corporate Governance Committee, creating immediate gaps in governance oversight that require committee restructuring.
The Board composition changes shift committee responsibilities, with Scott D. Kahn, Ph.D. and Charles McKhann now holding multiple committee chairs, potentially concentrating governance duties among fewer directors.

Want the newest filings?

This analysis covers the filing from 2026-04-23. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-01-12

Exagen Inc. announced preliminary unaudited financial results for Q4 and full-year 2025, indicating the company's financial closing procedures are not yet complete and final results may vary.
The company did not provide specific financial details, but noted the preliminary results are the responsibility of Exagen and have not been audited or reviewed by the company's auditor, BDO USA, P.C.
Exagen stated it will not update or supplement the preliminary information until it releases its full Q4 and full-year 2025 financial statements.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.